Author

Albert Pares 1

1 University of Barcelona,Barcelona,Spain

CHANGE IN BILIRUBIN WITH OBETICHOLIC ACID TREATMENT IN PRIMARY BILIARY CHOLANGITIS PATIENTS WITH HIGH BASELINE BILIRUBIN: A RETROSPECTIVE ANALYSIS OF POISE, 201, AND 202

Gideon Hirschfield, Mitchell Shiffman, Albert Pares, Elizabeth Smoot Malecha, Richard Pencek, Leigh MacConell, David Shapiro

CLINICAL IMPLICATION OF THE GLOBE SCORE – AN ACCURATE RISK STRATIFICATION TOOL IN URSODEOXYCHOLIC ACID TREATED PATIENTS WITH PRIMARY BILIARY CIRRHOSIS (PBC) – THE GLOBAL PBC STUDY GROUP

Willem J. Lammers, Gideon Hirschfield, Christophe Corpechot, Frederik Nevens, Keith D. Lindor, Harry L.A. Janssen, Annarosa Floreani, Marlyn J. Mayo, Pietro Invernizzi, Pier M. Battezzati, Albert Pares, Andrew K. Burroughs, Andrew L. Mason, Kris V. Kowdley, Teru Kumagi, Maren H. Harms, Palak J. Trivedi, Raoul Poupon, Ange

MACHINE LEARNING IN PRIMARY BILIARY CHOLANGITIS: A NOVEL APPROACH FOR RISK STRATIFICATION

Damiano Verda, Alessio Gerussi, Albert Pares, Davide Paolo Bernasconi, Atsumasa Komori, Masanori Abe, Mie Inao, Tadashi Namisaki, Satoshi Mochida, Hitoshi Yoshiji, Keith D. Lindor, Umberto Vespasiani-Gentilucci, Marco Carbone, Marco Marzioni, Christophe Corpechot, Annarosa Floreani, Gideon Hirschfield, Domenico Alvaro, La

RISK OF DEVELOPING PRIMARY BILIARY CHOLANGITIS IN PATIENTS WITH ISOLATED POSITIVE ANTI-MITOCHONDRIAL (AMA) ANTIBODIES

Laura Llovet, Guillem Soy, Jordi Gratacós-Ginès, Estíbaliz Ruíz-Ortíz, Odette Viñas, Albert Pares, Maria-Carlota Londoño

Item 1 - 4 / 5
1